Please login to the form below

Not currently logged in
Email:
Password:

Precision medicine

This page shows the latest Precision medicine news and features for those working in and with pharma, biotech and healthcare.

Regeneron’s early stage bispecific shows promise

Regeneron’s early stage bispecific shows promise

We believe that cancer treatment in the future will require precision medicine-based combinations of these and other approaches and that Regeneron is well positioned to be a future leader in

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Precision medicine, artificial intelligence, digital tech and genomic research are also all predicted to transform healthcare in the next decade, and public expectations won’t allow the NHS to stand still.

  • Leo has its eyes on the prize Leo has its eyes on the prize

    The weaponry is impressive but the task is daunting, as Ms Aabo outlines: “Precision medicine is developing in cancer but we are still scratching the surface in dermatology. ... Advancing biologics and adding biomarkers for precision medicine is one of

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    Fast-forward 18 years and more than ever we see the potential of how precision medicine could transform care. ... The appraisal system in the UK needs to reflect that specific genes and pathways underlying genetic diseases seldom respond to traditional

  • Let’s change the conversation about cancer Let’s change the conversation about cancer

    We are currently in the era of precision medicine with genetic typing of cancers and key biomarkers determining which next-generation treatment will be most effective.

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    Fast-forward 18 years and more than ever we see the potential of how precision medicine could transform care. But that can only happen if patients can access the medicines. ... The appraisal system in the UK needs to reflect that specific genes and

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics